Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Technology Digest.
Press releases published on September 29, 2025
Userful Introduces Infinity EdgeAI™, An Edge-Native Cognitive Intelligence Solution for Critical Workplace Management Applications, Co-Developed with Microsoft
Represents a critical evolution from traditional visual intelligence to real-time cognitive intelligence at the edge, accelerating the transition from reactive monitoring to proactive insight-driven decision-making in operations centers, factory floors, …
NopalCyber Launches Threat Hunting & Advisory Resource to Empower Security Teams with Actionable Intelligence
NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- NopalCyber, a leading global provider of managed extended detection and response (MXDR) and attack surface management solutions, announces the launch of a dedicated hub designed to help security teams stay ahead …
Zapier Adds Copilot Assistant and Enterprise-Grade Governance to AI Orchestration Platform
SAN FRANCISCO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Zapier, the most connected AI orchestration platform, today announced major upgrades to let every company drive impact with AI. Zapier has launched Copilot, made multiple core tools free, enhanced …
Zapier Announces 2025 Zappy Award Winners, Celebrating Leaders Who Transform Work with AI
SAN FRANCISCO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Zapier, the most connected AI orchestration platform, today announced the winners of its 2025 Zappy Awards. The awards honor 10 professionals from a variety of industries who are breaking new ground with AI …
Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025
– Rademikibart demonstrated rapid and significant improvement in lung function and asthma control in patients, with greatest improvements observed in those with elevated baseline levels of key type 2 inflammatory markers – – Significant reduction in …
Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates
Usman Azam, M.D., is appointed President and Chief Executive Officer of Cue Biopharma, effective September 29, 2025 Daniel Passeri, Chief Executive Officer of Cue Biopharma, transitions to Strategic Advisor to provide ongoing support to the Company Cue …
Vertesia Debuts ‘AI Assistant’: The Secure, Enterprise-Ready App for Every Employee
BROOKLYN, N.Y., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Vertesia, a leading provider of enterprise generative AI solutions, today introduced its enterprise AI Assistant, a new way for every employee to leverage the power of AI. AI Assistant offers a simple chat …
NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
CALABASAS, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today …
Progress Software Brings the Power of GenAI and RAG to OpenEdge Customers to Accelerate Development
Purpose-built MCP connector combines Generative AI (GenAI) and Retrieval-Augmented Generation (RAG), delivering domain-specific coding support to maximize value from OpenEdge data and applications BURLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- …
GreenOnyx Named “Vertical Farming Company of the Year” In 2025 AgTech Breakthrough Awards Program
TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) -- GreenOnyx, the company behind QFarming® technology that revolutionizes fresh food production through fully sterile, automated cultivation systems, announced it has been selected as "Vertical Farming …
Aptean Unveils AI-Powered Next Gen Routing and Scheduling Solution: Transforming Transportation and Logistics Operations
ALPHARETTA, Ga., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Aptean, a global provider of mission-critical enterprise software, today unveiled its Next Gen Routing and Scheduling solution, an AI-native platform which is purpose-built to transform transportation and …
Intermap Technologies Closes Bought Deal Public Offering for Gross Proceeds of $28,752,300, Including the Full Exercise of the Over-Allotment Option
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF) ("Intermap" or the "Company"), a global leader in 3D …
NETSOL Technologies Announces its Fiscal 2025 Fourth Quarter and Full-Year Results
FY’25 Total Revenue Increased 8% to $66 million 18% increase in Subscription and Support revenues to $32.9 million in FY’25 Q4’ 25 Gross Margins of 56.2% increased from 51.5% in Q4’ 24; FY’ 25 Gross Margins of 49.3% increased from 47.7% in FY ’24 FY’25 …
Outlook Therapeutics Provides Update on Type A Meeting with FDA
ISELIN, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has completed …
Global Mofy Charity Foundation Brings Mid-Autumn Warmth to Communities in Need
BEIJING, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use …
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares YAVNE, Israel, September 29, 2025 -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced …
SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children
Data show results consistent with clinical trial experience A high level of safety – no device-related adverse events Strong survival data extending to 90 days DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a …
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy
- Data from ongoing DELIVER trial demonstrated sustained functional improvement through 18 months; results from Registrational Expansion Cohort expected late 2025 - WALTHAM, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a …
Primech Holdings’ HYTRON Draws 250+ Qualified Client Inquiries at CMS Berlin 2025, Signaling Global Expansion
SINGAPORE, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. (“Primech AI” or the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), announced strong global traction from its first participation at CMS Berlin 2025, where the …
3D Systems Provides Update on Software Strategy
Primary focus on leveraging breakthroughs in AI to improve part quality, speed the design process for additive manufacturing, optimize manufacturing workflows and enhance ease-of-use in factory operating environments. Company to expand capabilities of 3D …